tiprankstipranks
Terragen Holdings Ltd (AU:TGH)
ASX:TGH
Australian Market
Want to see AU:TGH full AI Analyst Report?

Terragen Holdings Ltd (TGH) AI Stock Analysis

1 Followers

Top Page

AU:TGH

Terragen Holdings Ltd

(Sydney:TGH)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - Gpt-5.6Sol)
Rating:49Neutral
Price Target:
AU$0.02
▲(15.00% Upside)
Action:Reiterated
Date:08/28/26
The score is primarily held back by weak financial performance, led by deeply negative profitability and ongoing cash burn. Technical indicators are relatively neutral and suggest some stabilization, but not a strong uptrend. Valuation provides limited support because the negative P/E reflects continuing losses and no dividend yield is available to offset risk.
Positive Factors
Low Leverage
Very low leverage reduces refinancing pressure and interest-related strain, giving Terragen greater financial flexibility while it works to improve operations. However, this strength is supportive rather than sufficient because losses and cash burn continue to weaken overall financial durability.
Negative Factors
Deep Operating Losses
Extremely negative net and operating margins show that the current revenue base is insufficient to cover operating costs. This limits the prospect of self-sustaining growth and creates persistent dependence on the balance sheet or external funding until cost structure and sales improve materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Very low leverage reduces refinancing pressure and interest-related strain, giving Terragen greater financial flexibility while it works to improve operations. However, this strength is supportive rather than sufficient because losses and cash burn continue to weaken overall financial durability.
Read all positive factors

Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)

Terragen Holdings Ltd Business Overview & Revenue Model

Company Description
Based in Coolum Beach, Australia, and founded in 1996, Terragen Holdings Limited specializes in the innovation, production, and commercialization of biological products for the agricultural sector. The company distributes its solutions throughout ...
How the Company Makes Money
null...

Terragen Holdings Ltd Financial Statement Overview

Summary
Overall fundamentals are weak due to persistent losses and sustained cash burn. The income statement shows deeply negative profitability (2026 net margin ~-262% and operating margin ~-315%) and volatile/declining revenue trend despite a modest 2026 uptick. Cash flow remains a major risk with negative operating cash flow and free cash flow that worsened in 2026. The main offset is a comparatively healthier balance sheet with low leverage (debt-to-equity ~0.03x), which reduces near-term financial strain but does not solve ongoing losses.
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
14
Very Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.43M1.62M2.14M3.28M2.89M
Gross Profit524.91K792.23K2.06M3.21M2.62M
EBITDA-4.09M-4.68M-3.50M-3.46M-5.67M
Net Income-3.75M-3.72M-3.01M-3.23M-5.41M
Balance Sheet
Total Assets10.59M8.12M6.95M6.35M9.22M
Cash, Cash Equivalents and Short-Term Investments7.36M4.81M4.54M4.17M6.67M
Total Debt275.57K735.45K542.23K239.37K332.26K
Total Liabilities1.09M1.55M1.63M1.27M1.46M
Stockholders Equity9.50M6.57M5.32M5.08M7.76M
Cash Flow
Free Cash Flow-3.49M-3.03M-2.35M-2.91M-4.97M
Operating Cash Flow-3.38M-3.03M-2.32M-2.81M-4.80M
Investing Cash Flow-176.70K-682.43K-132.93K-35.20K-118.20K
Financing Cash Flow6.12M3.87M2.82M351.00K-52.70K

Terragen Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Positive
200DMA
0.02
Negative
Market Momentum
MACD
<0.01
Positive
RSI
51.84
Neutral
STOCH
28.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Positive. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.84 is Neutral, neither overbought nor oversold. The STOCH value of 28.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
53
Neutral
AU$15.05M-2.01-88.51%-0.48%-195.74%
50
Neutral
AU$1.27B-8.58-6.30%-1.53%-281.84%
49
Neutral
AU$18.93M-3.71-52.55%-11.34%30.34%
44
Neutral
AU$21.84M-7.01-8.97%94.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:TGH
Terragen Holdings Ltd
0.02
<0.01
43.75%
AU:CP8
Canadian Phosphate
0.16
0.09
146.03%
AU:NUF
Nufarm Limited
3.29
0.96
41.20%
AU:AMN
Agrimin Limited
0.05
-0.04
-43.16%
AU:RLF
RLF AgTech Ltd
0.03
-0.02
-46.00%
AU:KM1
Kali Metals Limited
0.10
-0.08
-44.44%

Terragen Holdings Ltd Corporate Events

Terragen Details Compliance With ASX Corporate Governance Standards
Aug 25, 2026
Terragen Holdings Limited has detailed its corporate governance practices for the 2025&#8211;26 financial year, confirming alignment with the ASX Corporate Governance Council&#8217;s latest principles and recommendations. The board emphasises clea...
Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes
Aug 25, 2026
Terragen Holdings Limited, an agricultural biotechnology company, develops and markets biological products aimed at improving livestock and crop performance for farmers and agribusiness clients. Operating in a specialised agri-tech niche, the comp...
Terragen targets large-scale cattle probiotics rollout with new feedlot deals
Jul 30, 2026
Terragen Holdings Limited has secured conditional supply agreements that mark its first large-scale commercial deployment of Terragen Probiotic for Ruminants and Great Land Plus into major feedlot operations. The company signed a landmark agreemen...
Terragen strengthens executive ranks with new CFO to drive growth strategy
Jul 6, 2026
Terragen Holdings Limited has appointed Daniel Pearce as Chief Financial Officer and Joint-Company Secretary, effective immediately, strengthening its executive team as it pursues growth in biological agriculture. Pearce replaces outgoing CFO Roge...
Terragen Plans Issue of 1 Million Unlisted Options
May 28, 2026
Terragen Holdings Ltd has lodged a notice with the ASX outlining a proposed issue of up to 1,000,000 unlisted options as part of a placement or similar capital initiative. The options, which are scheduled for issue on 1 March 2027, represent a tar...
Terragen Lands First Major Feedlot Deal and Backing for Probiotic Cattle Trial
May 28, 2026
Terragen Holdings has signed its first large-scale commercial supply agreement with Ramps Ridge&#8217;s Ravensworth feedlot in New South Wales, covering a minimum 360,000 doses of Terragen Probiotic for Ruminants and Great Land Plus from late 2026...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 28, 2026